How much should you hold?
- Overall Portfolio exposure to Anlon Healthcare should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
30.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.89%
ROCE (avg)
9.07%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
36
Price to Book Value
7.15
EV to EBIT
33.65
EV to EBITDA
32.53
EV to Capital Employed
6.12
EV to Sales
8.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.78%
ROE (Latest)
13.85%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
No Trend
OBV
Bullish
No Trend
Technical Movement
2What is working for the Company
NET SALES(9M)
At Rs 121.98 cr has Grown at 33.18%
-9What is not working for the Company
PAT(Q)
At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average
NET SALES(Q)
Lowest at Rs 30.98 cr
Loading Valuation Snapshot...
Here's what is not working for Anlon Healthcare
Net Sales - Quarterly
At Rs 30.98 cr has Fallen at -29.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 44.13 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.95 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 30.98 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)